Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Slow-acting antirheumatic drugs.

A G Mowat

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |March 6, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Slow-acting drugs and treatments are increasingly used to manage rheumatoid arthritis. Further research into their mechanisms may unlock a deeper understanding of this complex disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

    Arthritis research·2000
    Same author

    Surgery for rheumatoid arthritis of the elbow: a comparison of radial-head excision and synovectomy with total elbow replacement.

    Journal of shoulder and elbow surgery·1999
    Same author

    Synovectomy of the elbow and radial head excision in rheumatoid arthritis. Predictive factors and long-term outcome.

    The Journal of bone and joint surgery. British volume·1997
    Same author

    Lupus-like syndrome in patients treated for acne.

    British journal of rheumatology·1995
    Same author

    Arthrotec in general practice. Proceedings from the clinical investigator meeting held May 1994, Leeds, UK.

    European journal of rheumatology and inflammation·1994
    Same author

    Unusual cysts around the knee: two case reports.

    British journal of rheumatology·1994

    Area of Science:

    • Immunology
    • Pharmacology
    • Rheumatology

    Background:

    • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
    • Current management of RA involves a growing arsenal of slow-acting drugs and therapies.
    • The precise mechanisms of action for many of these treatments remain incompletely understood.

    Purpose of the Study:

    • To explore the potential of existing and emerging slow-acting treatments for rheumatoid arthritis.
    • To investigate the underlying, often unexplained, modes of action of these therapeutic agents.
    • To determine how understanding these mechanisms can advance the scientific comprehension of RA pathogenesis.

    Main Methods:

    • Review of current pharmacological and therapeutic interventions for rheumatoid arthritis.

    Related Experiment Videos

  • Analysis of the scientific literature concerning the mechanisms of action of slow-acting RA drugs.
  • Exploration of the link between treatment efficacy and a rational basis for their action.

    • Main Results:

    • An expanding range of slow-acting drugs and treatments are available for rheumatoid arthritis management.
    • The modes of action for many of these therapies are not yet fully elucidated.
    • These unexplained mechanisms represent a potential avenue for gaining significant insights into RA.

    Conclusions:

    • The increasing use of slow-acting treatments in rheumatoid arthritis offers opportunities for disease control.
    • Further investigation into the mechanisms of action of these drugs is crucial.
    • Unraveling these mechanisms promises to enhance our fundamental understanding of rheumatoid arthritis.